Semaphorins in bone development, homeostasis, and disease

Seminars in Cell and Developmental Biology

Volumn 24, Issue 3, 2013, Pages 163-171

  Kang, Sujin ^a,b   Kumanogoh, Atsushi ^a,b,c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Bone remodeling; Osteopetrosis; Osteoporosis; Semaphorin

Indexed keywords

PLEXIN; PLEXIN A1; PLEXIN B1; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 6D; SEMAPHORIN 7A; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; BONE DISEASE; BONE HOMEOSTASIS; BONE REMODELING; CARBOXY TERMINAL SEQUENCE; CELL COMMUNICATION; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; OSTEOPOROSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84875630392     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.09.008     Document Type: Review

References (85)

1. Kolodkin A.L., Matthes D.J., Goodman C.S. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993, 75:1389-1399.
2. communittee Sn. Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee. Cell 1999; 97:551-2.
3. Toyofuku T., Yabuki M., Kamei J., Kamei M., Makino N., Kumanogoh A., et al. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO Journal 2007, 26:1373-1384.
4. Toyofuku T., Yoshida J., Sugimoto T., Yamamoto M., Makino N., Takamatsu H., et al. Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells. Developmental Biology 2008, 321:251-262.
5. Serini G., Valdembri D., Zanivan S., Morterra G., Burkhardt C., Caccavari F., et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003, 424:391-397.
6. Gu C., Yoshida Y., Livet J., Reimert D.V., Mann F., Merte J., et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 2005, 307:265-268.
7. Sekido Y., Bader S., Latif F., Chen J.Y., Duh F.M., Wei M.H., et al. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proceedings of the National Academy of Sciences United States of America 1996, 93:4120-4125.
8. Suzuki K., Kumanogoh A., Kikutani H. Semaphorins and their receptors in immune cell interactions. Nature Immunology 2008, 9:17-23.
9. Takamatsu H, Kumanogoh A. Diverse roles for semaphorin-plexin signaling in the immune system. Trends in Immunology 33:127-35.
10. Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A, Takayanagi H. Osteoprotection by semaphorin 3A. Nature 485:69-74.
11. Negishi-Koga T, Shinohara M, Komatsu N, Bito H, Kodama T, Friedel RH, et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nature Medicine 17:1473-80.
12. Takegahara N., Takamatsu H., Toyofuku T., Tsujimura T., Okuno T., Yukawa K., et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nature Cell Biology 2006, 8:615-622.
13. Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee. Cell 1999; 97:551-2.
14. Takahashi T., Fournier A., Nakamura F., Wang L.H., Murakami Y., Kalb R.G., et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999, 99:59-69.
15. Tamagnone L., Artigiani S., Chen H., He Z., Ming G.I., Song H., et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999, 99:71-80.
16. Winberg M.L., Noordermeer J.N., Tamagnone L., Comoglio P.M., Spriggs M.K., Tessier-Lavigne M., et al. Plexin A is a neuronal semaphorin receptor that controls axon guidance. Cell 1998, 95:903-916.
17. Kumanogoh A., Marukawa S., Suzuki K., Takegahara N., Watanabe C., Ch'ng E., et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 2002, 419:629-633.
18. Kumanogoh A., Watanabe C., Lee I., Wang X., Shi W., Araki H., et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 2000, 13:621-631.
19. Kang S, Okuno T, Takegahara N, Takamatsu H, Nojima S, Kimura T, et al. Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via alphavbeta1 integrin. Journal of Immunology 188:1108-16.
20. Pasterkamp R.J., Peschon J.J., Spriggs M.K., Kolodkin A.L. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 2003, 424:398-405.
21. Suzuki K., Okuno T., Yamamoto M., Pasterkamp R.J., Takegahara N., Takamatsu H., et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 2007, 446:680-684.
22. Kruger R.P., Aurandt J., Guan K.L. Semaphorins command cells to move. Nature Reviews Molecular Cell Biology 2005, 6:789-800.
23. Giordano S., Corso S., Conrotto P., Artigiani S., Gilestro G., Barberis D., et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nature Cell Biology 2002, 4:720-724.
24. Swiercz J.M., Worzfeld T., Offermanns S. ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. Journal of Biological Chemistry 2008, 283:1893-1901.
25. Martin T.J., Sims N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends in Molecular Medicine 2005, 11:76-81.
26. Hayden J.M., Mohan S., Baylink D.J. The insulin-like growth factor system and the coupling of formation to resorption. Bone 1995, 17:93S-98S.
27. Tang Y., Wu X., Lei W., Pang L., Wan C., Shi Z., et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nature Medicine 2009, 15:757-765.
28. Walker E.C., McGregor N.E., Poulton I.J., Pompolo S., Allan E.H., Quinn J.M., et al. Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. Journal of Bone and Mineral Research 2008, 23:2025-2032.
29. Taylor A.C., Murfee W.L., Peirce S.M. EphB4 expression along adult rat microvascular networks: EphB4 is more than a venous specific marker. Microcirculation 2007, 14:253-267.
30. Crockett JC, Rogers MJ, Coxon FP, Hocking LJ, Helfrich MH. Bone remodelling at a glance. Journal of Cell Science 124:991-8.
31. Dacquin R, Domenget C, Kumanogoh A, Kikutani H, Jurdic P, Machuca-Gayet I. Control of bone resorption by semaphorin 4D is dependent on ovarian function. PLoS One 6: e26627.
32. Hwang J.Y., Lee J.Y., Park M.H., Kim K.S., Kim K.K., Ryu H.J., et al. Association of PLXNA2 polymorphisms with vertebral fracture risk and bone mineral density in postmenopausal Korean population. Osteoporosis International 2006, 17:1592-1601.
33. Koh J.M., Oh B., Lee J.Y., Lee J.K., Kimm K., Kim G.S., et al. Association study of semaphorin 7a (sema7a) polymorphisms with bone mineral density and fracture risk in postmenopausal Korean women. Journal of Human Genetics 2006, 51:112-117.
34. Takegahara N, Kang S, Nojima S, Takamatsu H, Okuno T, Kikutani H, et al. Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements. FASEB Journal 24:4782-92.
35. Furuyama T., Inagaki S., Kosugi A., Noda S., Saitoh S., Ogata M., et al. Identification of a novel transmembrane semaphorin expressed on lymphocytes. Journal of Biological Chemistry 1996, 271:33376-33381.
36. Hall K.T., Boumsell L., Schultze J.L., Boussiotis V.A., Dorfman D.M., Cardoso A.A., et al. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proceedings of the National Academy of Sciences United States of America 1996, 93:11780-11785.
37. Delaire S., Billard C., Tordjman R., Chedotal A., Elhabazi A., Bensussan A., et al. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. Journal of Immunology 2001, 166:4348-4354.
38. Klostermann A., Lohrum M., Adams R.H., Puschel A.W. The chemorepulsive activity of the axonal guidance signal semaphorin D requires dimerization. Journal of Biological Chemistry 1998, 273:7326-7331.
39. Elhabazi A., Delaire S., Bensussan A., Boumsell L., Bismuth G. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. Journal of Immunology 2001, 166:4341-4347.
40. Herold C., Bismuth G., Bensussan A., Boumsell L. Activation signals are delivered through two distinct epitopes of CD100, a unique 150kDa human lymphocyte surface structure previously defined by BB18 mAb. International Immunology 1995, 7:1-8.
41. Wang X., Kumanogoh A., Watanabe C., Shi W., Yoshida K., Kikutani H. Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 2001, 97:3498-3504.
42. Janssen BJ, Robinson RA, Perez-Branguli F, Bell CH, Mitchell KJ, Siebold C, et al. Structural basis of semaphorin-plexin signalling. Nature 467:1118-22.
43. Love C.A., Harlos K., Mavaddat N., Davis S.J., Stuart D.I., Jones E.Y., et al. The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. Nature Structural Biology 2003, 10:843-848.
44. Zhu L., Bergmeier W., Wu J., Jiang H., Stalker T.J., Cieslak M., et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proceedings of the National Academy of Sciences United States of America 2007, 104:1621-1626.
45. Shi W., Kumanogoh A., Watanabe C., Uchida J., Wang X., Yasui T., et al. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 2000, 13:633-642.
46. Basile J.R., Barac A., Zhu T., Guan K.L., Gutkind J.S. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Research 2004, 64:5212-5224.
47. Basile J.R., Afkhami T., Gutkind J.S. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Molecular and Cellular Biology 2005, 25:6889-6898.
48. Wu X, Pang L, Lei W, Lu W, Li J, Li Z, et al. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 7:571-80.
49. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Reviews 1999, 20:345-357.
50. Zhao C., Irie N., Takada Y., Shimoda K., Miyamoto T., Nishiwaki T., et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metabolism 2006, 4:111-121.
51. Driessens M.H., Olivo C., Nagata K., Inagaki M., Collard J.G. B plexins activate Rho through PDZ-RhoGEF. FEBS Letters 2002, 529:168-172.
52. Perrot V., Vazquez-Prado J., Gutkind J.S. Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. Journal of Biological Chemistry 2002, 277:43115-43120.
53. Swiercz J.M., Kuner R., Behrens J., Offermanns S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 2002, 35:51-63.
54. Diarra D., Stolina M., Polzer K., Zwerina J., Ominsky M.S., Dwyer D., et al. Dickkopf-1 is a master regulator of joint remodeling. Nature Medicine 2007, 13:156-163.
55. Matsumoto T, Abe M. TGF-beta-related mechanisms of bone destruction in multiple myeloma. Bone 48:129-34.
56. Behar O., Golden J.A., Mashimo H., Schoen F.J., Fishman M.C. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 1996, 383:525-528.
57. Taniguchi M., Yuasa S., Fujisawa H., Naruse I., Saga S., Mishina M., et al. Disruption of semaphorin III/D gene causes severe abnormality in peripheral nerve projection. Neuron 1997, 19:519-530.
58. Toyofuku T., Zhang H., Kumanogoh A., Takegahara N., Suto F., Kamei J., et al. Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Development 2004, 18:435-447.
59. Wong A.W., Brickey W.J., Taxman D.J., van Deventer H.W., Reed W., Gao J.X., et al. CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions. Nature Immunology 2003, 4:891-898.
60. Kaifu T., Nakahara J., Inui M., Mishima K., Momiyama T., Kaji M., et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. Journal of Clinical Investigation 2003, 111:323-332.
61. Koga T., Inui M., Inoue K., Kim S., Suematsu A., Kobayashi E., et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 2004, 428:758-763.
62. Turner L.J., Nicholls S., Hall A. The activity of the plexin-A1 receptor is regulated by Rac. Journal of Biological Chemistry 2004, 279:33199-33205.
63. Kubo T., Yamashita T., Yamaguchi A., Sumimoto H., Hosokawa K., Tohyama M. A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling. Journal of Neuroscience 2002, 22:8504-8513.
64. Toyofuku T., Yoshida J., Sugimoto T., Zhang H., Kumanogoh A., Hori M., et al. FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nature Neuroscience 2005, 8:1712-1719.
65. He Z., Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997, 90:739-751.
66. Potiron V., Roche J. Class 3 semaphorin signaling: the end of a dogma. Science STKE 2005, 2005:pe24.
67. Takamatsu H, Takegahara N, Nakagawa Y, Tomura M, Taniguchi M, Friedel RH, et al. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nature Immunology 11:594-600.
68. Sims N.A., Gooi J.H. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Seminars in Cell & Developmental Biology 2008, 19:444-451.
69. Kawai M, Modder UI, Khosla S, Rosen CJ. Emerging therapeutic opportunities for skeletal restoration. Nature Reviews Drug Discovery; 10:141-56.
70. Cawthorn WP, Bree AJ, Yao Y, Du B, Hemati N, Martinez-Santibanez G, et al. Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a beta-catenin-dependent mechanism. Bone 50:477-89.
71. Pickett C.L., Breen K.T., Ayer D.E. A C. elegans Myc-like network cooperates with semaphorin and Wnt signaling pathways to control cell migration. Developmental Biology 2007, 310:226-239.
72. Kagoshima M., Ito T. Diverse gene expression and function of semaphorins in developing lung: positive and negative regulatory roles of semaphorins in lung branching morphogenesis. Genes Cells 2001, 6:559-571.
73. Li C., Xiao J., Hormi K., Borok Z., Minoo P. Wnt5a participates in distal lung morphogenesis. Developmental Biology 2002, 248:68-81.
74. Shu W., Jiang Y.Q., Lu M.M., Morrisey E.E. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002, 129:4831-4842.
75. Nagashima M., Sakai A., Uchida S., Tanaka S., Tanaka M., Nakamura T. Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur. Bone 2005, 36:502-511.
76. Angelisova P., Drbal K., Cerny J., Hilgert I., Horejsi V. Characterization of the human leukocyte GPI-anchored glycoprotein CDw108 and its relation to other similar molecules. Immunobiology 1999, 200:234-245.
77. Lange C., Liehr T., Goen M., Gebhart E., Fleckenstein B., Ensser A. New eukaryotic semaphorins with close homology to semaphorins of DNA viruses. Genomics 1998, 51:340-350.
78. Xu X., Ng S., Wu Z.L., Nguyen D., Homburger S., Seidel-Dugan C., et al. Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins. Journal of Biological Chemistry 1998, 273:22428-22434.
79. Comeau M.R., Johnson R., DuBose R.F., Petersen M., Gearing P., VandenBos T., et al. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor VESPR. Immunity 1998, 8:473-482.
80. Holmes S., Downs A.M., Fosberry A., Hayes P.D., Michalovich D., Murdoch P., et al. Sema7A is a potent monocyte stimulator. Scandinavian Journal of Immunology 2002, 56:270-275.
81. Gronthos S., Stewart K., Graves S.E., Hay S., Simmons P.J. Integrin expression and function on human osteoblast-like cells. Journal of Bone and Mineral Research 1997, 12:1189-1197.
82. Helfrich M.H., Nesbitt S.A., Lakkakorpi P.T., Barnes M.J., Bodary S.C., Shankar G., et al. Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone 1996, 19:317-328.
83. Delorme G., Saltel F., Bonnelye E., Jurdic P., Machuca-Gayet I. Expression and function of semaphorin 7A in bone cells. Biology of the Cell 2005, 97:589-597.
84. Sutton A.L., Zhang X., Dowd D.R., Kharode Y.P., Komm B.S., Macdonald P.N. Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice. Molecular Endocrinology 2008, 22:1370-1381.
85. Gitler A.D., Lu M.M., Epstein J.A. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Developmental Cell 2004, 7:107-116.